Analysis of GC patients from TCGA demonstrated that patients with higher SCAMP1 levels had shorter survival (OS cutoff point: high, 28.8 months vs. low, 68.4 months; P = 0.029) (Figure 1D). This evidence concerns the gene SCAMP1 and gastric cancer.